U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415226) titled 'Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes' on Feb. 10.
Brief Summary: To assess the real-world impact of glucose-lowering drugs (GLDs) as an adjunct to insulin in Chinese patients with type 1 diabetes (T1DM).
Does glucose-lowering drugs (GLDs) as an adjunct to insulin improve clinical outcomes in Chinese patients with type 1 diabetes (T1DM) when used long-term in real-world practice?
Study Start Date: May 01, 2026
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes Mellitus
Intervention:
DRUG: GLD+insulin group
The glucose-lowering drugs included in the analysis were me...